Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis
Yunfei Zhou(Roswell Park Comprehensive Cancer Center), Michael G. Brattain(Roswell Park Comprehensive Cancer Center)
Cited by 96
Related Papers
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
|Cancer Research|2011|376
Sumoylation Inhibits Cleavage of Sp1 N-terminal Negative Regulatory Domain and Inhibits Sp1-dependent Transcription
|Journal of Biological Chemistry|2006|86
Colon carcinoma cells harboring <i>PIK3CA</i> mutations display resistance to growth factor deprivation induced apoptosis
|Molecular Cancer Therapeutics|2007|61
Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells
|Journal of Biological Chemistry|2005|25